About Saprogal
Saprogal was founded in 1991 in Vila Real, Portugal, within the pharmaceutical sector focused on child health. Medications tailored for common childhood illnesses are developed and produced, alongside medical devices that support pediatric care. Operations are conducted across multiple facilities equipped with advanced automation. Stringent quality control standards are applied throughout the research, development, and manufacturing processes to ensure product safety and efficacy.
- Headquarter Vila Real, Portugal
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Saprogal
Investors in Saprogal
Saprogal has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Alantra, pascual and De Heus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity capital is invested in small and mid-sized businesses.
|
Locked | Locked | Locked | |
|
Multi-category beverages are manufactured and branded by Pascual.
|
Locked | Locked | Locked | |
|
Global mid-market investment banking services are provided across sectors.
|
Locked | Locked | Locked |
Investor details for Saprogal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Saprogal
Investment portfolio details for Saprogal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Saprogal
Detailed financials for Saprogal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Saprogal Comparisons
Peer comparison for Saprogal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Saprogal
Detailed competitors of Saprogal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Saprogal
Complete news archive for Saprogal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saprogal
Saprogal was founded in 1991 and raised its 1st funding round 19 years after it was founded.
Saprogal is headquartered in Vila Real, Portugal. It is registered at Vila Real, Vila Real, Portugal.
Saprogal was founded in 1991 in Vila Real, Portugal, within the pharmaceutical sector focused on child health. Medications tailored for common childhood illnesses are developed and produced, alongside medical devices that support pediatric care. Operations are conducted across multiple facilities equipped with advanced automation. Stringent quality control standards are applied throughout the research, development, and manufacturing processes to ensure product safety and efficacy.
Saprogal has 4 investors. Key investors include Alantra, pascual, De Heus, and H.I.G. Capital.